Search results for: “UK market”
-
FCA publishes review into unsecured credit market
•
LONDON: The Financial Conduct Authority (FCA) has published a report on change and innovation in the unsecured consumer…
-
PSX holds Ceremony for onboarding of Meezan Bank as market maker
•
KARACHI: A Gong Ceremony was held at Pakistan Stock Exchange (PSX) to welcome Meezan Bank Limited on-board as…
-
PSX 2nd best performing market in the region
•
Pakistan stock market emerges as 2nd best performing market in the region and 7th best performing market in…
-
Highland Grow signs cannabis supply agreement with Yukon Liquor Corporation
•
VANCOUVER: MYM Nutraceuticals Inc. announced its wholly owned subsidiary and Health Canada licensed cannabis producer, Highland Grow Inc.…
-
Agreement signed for onboarding of MRA Securities as market maker of ETFs
•
KARACHI: In a very positive development for Pakistan’s capital market, an agreement has been signed between Pakistan Stock…
-
Avacta signs collaboration agreement with Bruker
•
LONDON: Avacta Group plc has entered into a collaboration agreement with Bruker Corporation to evaluate the Affimer-based, bead…
-
Patrick Tiernan to join Lloyd’s as Chief of Markets
•
LONDON: Lloyds of London announced that Patrick Tiernan will be joining the Corporation in the newly created role…
-
Plc Uutechnic Group Oyj’s CEO Jouko Peräaho steps down position, Dominic Hill appointed new CEO
•
HELSINKI: Plc Uutechnic Group Oyj’s CEO Jouko Peräaho steps down from his position as the company’s CEO. Peräaho…
-
Kromek receives Innovate UK funding to advance biological-threat detection solution
•
LONDON: Kromek Group, a worldwide supplier of detection technology, has commenced a £1.25 million programme funded by Innovate…
-
Bluefield Solar acquires 70 MWp UK-based Bradenstoke Solar Park
•
LONDON: Bluefield Solar has acquired Bradenstoke Solar Park Limited, an operational 70 megawatt peak (‘MWp’) ground mounted solar…
-
Lysogene gets MHRA and Research Ethics Committee approvals for Gene Therapy Clinical Trial in the UK
•
PARIS: Lysogene, a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, has received MHRA…
-
Peter Madouros appointed Chief Investment Officer at Duke Royalty Limited
•
LONDON: Duke Royalty Limited, a provider of capital solutions to a diversified range of profitable and long-established businesses…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.